Found vs LTTL: Practical comparison of pricing, meds, and oversight
Found vs LTTL: quick verdict up front. Found emphasizes a biology-first, personalized medically supervised program with affordable monthly plans starting at as low as $39 and broad insurance support. LTTL focuses on compounded full-dose GLP-1 delivery from U.S. licensed pharmacies with offers like up to $140 off your first month; treatment is available only when a licensed clinician determines it is medically appropriate.
Found vs LTTL: what the two providers prioritize
The core difference in this comparison is approach. Found builds personalized programs around an individual’s metabolic biology, targeting hormones, blood sugar regulation, sleep, and behavior, while LTTL centers on clinician-reviewed access to compounded full-dose GLP-1 medications prepared by state-licensed pharmacies. Both mention compounded GLP-1s and include regulatory notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Early availability, pricing and insurance
Found advertises getting started for as low as $39, with statements that most insurance is now accepted and that Found handles insurance paperwork. Found also notes advertised pricing for branded GLP-1s via insurance may involve a 12 month commitment and that copays, coinsurance and deductibles may apply. LTTL’s pricing highlights include offers of up to $140 off your first month via an auto-applied code and statements like same price, every dose; LTTL also frames payment as no insurance needed for full-dose GLP-1 delivery.
Medication sourcing and quality checks
Found lists compounded semaglutide and tirzepatide among offerings and includes the regulatory qualifier that compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy and are not available in all states. LTTL states its compounded GLP-1 medications are prepared by U.S.A. licensed pharmacies, independently verified in FDA registered labs, and confirmed every 3 to 6 months to stay within plus or minus 10 percent of target strength. LTTL also repeats that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Direct comparison table
| Criteria | Found | LTTL |
|---|---|---|
| Starting price | Get started for as low as $39 | Starting price listed as $140; up to $140 off first month |
| Approach | Biology-first personalized medically supervised program | Clinician-reviewed access to compounded full-dose GLP-1 medications |
| Insurance | Most insurance now accepted; Found handles insurance paperwork | No insurance needed; confirm eligibility and terms |
| Compounded meds | Offers compounded semaglutide and tirzepatide; note: not FDA-approved | Compounded by U.S. licensed pharmacies; verified in FDA registered labs; not FDA-approved |
| Quality checks | Regulatory note that compounded meds are not FDA-approved | Confirmed every 3-6 months to stay within ± 10% of target strength; regulatory note that compounded meds are not FDA-approved |
| Best for | People who want weight loss built around their biology | People who confirm eligibility, medication, total cost, renewal terms and state availability before enrollment |
Differences that matter
1) Personalization vs medication delivery: Found emphasizes a holistic, biology-based program that integrates hormones, metabolism and behavior. LTTL emphasizes reliable compounded medication sourcing and dose verification from licensed pharmacies.
2) Insurance handling and pricing presentation: Found highlights insurance acceptance and handling paperwork and advertises plans starting at $39; LTTL promotes upfront full-dose delivery without insurance and promotional first-month offsets up to $140.
3) Quality verification statements: LTTL explicitly notes independent verification in FDA registered labs and batch confirmation every 3 to 6 months within a ± 10 percent target strength range. Found reiterates that compounded GLP-1s are not FDA-approved and not available in all states and frames offerings alongside insurance-based options and branded GLP-1 access with commitments.
See LTTL compounded GLP-1 details
Limitations and regulatory notes
Both providers include the regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Found additionally states compounded GLP-1s are not available in all states and that prescriptions are subject to provider review and clinical eligibility. LTTL states treatment is available only when a licensed clinician determines it is medically appropriate and notes that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Explore Found membership and insurance options
How to choose between Found and LTTL
Choose Found if you want a biology-first, personalized medically supervised weight loss program, want insurance handled by the provider, and value starting plans advertised as low as $39. Choose LTTL if you prioritize compounded full-dose GLP-1 delivery from U.S. licensed pharmacies with independent lab verification and offers like up to $140 off your first month, and if you understand treatment is clinician-determined.
Check LTTL eligibility and offers
Final note: Found vs LTTL highlights personalization and insurance support vs pharmacy-verified compounded GLP-1 delivery; compounded medications from both are not FDA-approved.